An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis

Journal of Ethnopharmacology

Volumn 85, Issue 2-3, 2003, Pages 207-215

  Laupattarakasem, P ^a,d   Houghton, P J ^a   Hoult, J R S ^b   Itharat, A ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^d KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Acanthus ebracteatus; Anti inflammatory; Antioxidant; Cryptolepis buchanani; Derris scandens; Eicosanoid inhibition; Oroxylum indicum

Indexed keywords

ACANTHUS EBRACTEATUS EXTRACT; ANTIINFLAMMATORY AGENT; CRYPTOLEPIS BUCHANANI EXTRACT; DERRIS SCANDENS EXTRACT; LEUKOTRIENE B4; MYELOPEROXIDASE; OROXYLUM INDICUM EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACANTHACEAE; ACANTHUS EBRACTEATUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTHRITIS; ARTICLE; BIGNONIACEAE; CAESALPINIA; CONTROLLED STUDY; CRYPTOLEPSIS BUCHANANI; DERRIS SCANDENS; DRUG ACTIVITY; DRUG INHIBITION; DRUG SCREENING; EDEMA; ENZYME RELEASE; LEGUME; MALE; MEDICINAL PLANT; NONHUMAN; OROXYLUM INDICUM; PAW EDEMA; PIPERACEAE; RAT; RUBIACEAE; RUTACEAE; THAILAND; ZINGIBERACEAE;

ACANTHUS EBRACTEATUS; CRYPTOLEPIS BUCHANANI; DERRIS SCANDENS; OROXYLUM INDICUM;

EID: 0037375104     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(02)00367-7     Document Type: Article

References (19)

1. Ali R.M., Houghton P.J., Hoult J.R.S. Antimicrobial and antiinflammatory activities of extracts and constituents of Oroxylum indicum (L.). Ventional Phytomedicine. 5:1998;375-381.
2. Bauer, R., 1999. Cycloxygenase and 5-lipoxygenase as targets for medicinal plant research. In: L. Bohlin, J.G. Bruhn (Eds.), Bioassay Methods in Natural Products Research and Drug Development. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp. 119-142.
3. Bird T., Bruneau P., Crawley G., Edwards M., Foster S., Girodeau J.-M., Kingston J., McMillan R. Methoxyalkylthiazoles: a new series of potent, selective and orally active 5-lipoxygenase inhibitors displaying high enantioselectivity. Journal of Medicinal Chemistry. 34:1991;2176-2186.
4. Bisgaard H. Role of leukotrienes in asthma pathophysiology. Pediatric Pulmonology. 30:2000;166-176.
5. Bley K.R., Hunter J.C., Eglen R.M., Smith J.A.M. The role of IP prostanoid receptors in inflammatory pain. Trends in Pharmacological Sciences. 19:1998;141-147.
6. Cuzzocrea S., Riley D.P., Caputi A.P., Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation and ischemia/reperfusion injury. Pharmacology Reviews. 53:2001;135-159.
7. De las Heras B., Hoult J.R.S. Non-cytotoxic inhibition of macrophage eicosanoid biosynthesis and effects on leukocyte functions and reactive oxygen species of two novel anti-inflammatory plant diterpenoids. Planta Medica. 60:1994;501-506.
8. Halliwell, B., Gutteridge, J.M.C., 1998. Free Radicals in Biology and Medicine, 3rd ed. Oxford University Press, Oxford.
9. Hawkey C.J. COX-2 inhibitors. Lancet. 353:1999;307-331.
10. Hogg N. Free radicals in disease. Seminars in reproductive. Endocrinology. 16:1998;241-248.
11. Houghton P.J. Use of small scale bioassays in the discovery of novel drugs from natural sources. Phytotherapy Research. 14:2000;419-423.
12. Hoult J.R.S., Moroney M.A., Paya M. Actions of flavonoids and coumarins on lipoxygenase and cycloxygenase. Methods in Enzymology. 234:1994;443-454.
13. Hoult J.R.S., Pang L.-H., Bland-Ward P., Forder R., Williams C., Harborne J.B. Inhibition of leukocyte 5-lipoxygenase and cyclooxygenase but not constitutive nitric oxide synthase by tanetin, a novel flavonoid derived from feverfew Tanacetum parthenium. Pharmaceutical Sciences. 1:1995;71-74.
14. Moroney M.A., Alcaraz M.J., Forder R.A., Carey F., Hoult J.R.S. Selectivity of neutrophil 5-lipoxygenase and cyclooxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. Journal of Pharmacy and Pharmacology. 40:1988;787-792.
15. Paya M., Halliwell B., Hoult J.R.S. Interactions of a series of coumarins with reactive oxygen species. Biochemical Pharmacology. 44:1992;205-214.
16. Paya M., Goodwin P.A., de las Heras B., Hoult J.R.S. Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins. Biochemical Pharmacology. 48:1994;445-451.
17. Scott K.F., Bryant K.J., Bidgood M.J. Functional coupling and differential regulation of the phospholipase A2-cycloxygenase pathways in inflammation. Journal of Leukocyte Biology. 66:1999;535-541.
18. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A., Talley J.J., Masferrer J.L., Seibert K., Isakson P.C. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proceedings of the National Academy of Sciences of the USA. 95:1998;13313-13318.
19. Winter C., Risley E., Nuss G. Carrageenin-induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs. Proceedings of the Society for Experimental Biology and Medicine. 111:1962;544-547.